Ledger.Open graph →

SEC Form D · filed August 11, 2022

AEON Biopharma, Inc

Offering

$25.0M

Sold

$24.5M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

IRVINE, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Richard Taketa · Irvine, CADirector Chad Oh · Irvine, CAExec Robert Grant · Irvine, CADirector Marc Forth · Irvine, CAExec Vikram Malik · Irvine, CADirector Jost Fischer · Irvine, CADirector Alex Wilson · Irvine, CAExec Simone Blank · Irvine, CADirector Darren O'Brien · Irvine, CADirector Chris Carr · Irvine, CAExec Beth M. Cranis · Austin, TXExec Erik Gustafson · Boston, MADirector Rockstep Fund I Management LLC · Houston, TXDirector Marc Feliciano · Boston, MADirector Aidan Kehoe · New York, NYExec Jessica Lee · Boston, MADirector Spencer R. Powers · Chicago, ILExec L.L.C. TMG Parkside GP · Bethesda, MDExec Cody Shandraw · Jupiter, FLDirector Marie Claire Hickey · San Mateo, CADirector Jeremy D. Boughton · Pittsburgh, PADirector Ed Boyle · Houston, TXDirector Sean Churchill · Houston, TXDirector Sarah Farrell · San Francisco, CADirector John Dickinson · San Francisco, CAExec Robert Frisbie, Jr · Palm Beach, FLExec Cody Crowell · Palm Beach, FLDirector Angelo A. Rufino · New York, NYDirector Anil Hingorani · Mountain Lakes, NJExec Brian Shin · Reno, NVExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗